Clinicopathological characteristics and prognosis of brain metastases in elderly patients with esophageal carcinoma

Abstract Background Brain metastases (BM) from esophageal carcinoma (EC) is clinically rare and has not yet been reported in elderly patients. This study aimed to investigate the clinicopathological characteristics, outcomes and prognostic factors of BM in elderly patients with EC, in order to provi...

Full description

Bibliographic Details
Main Authors: Yi Wang, Linlin Xiao, Jiandong Zhang, Xiaoyan Lv, Feng Cao, Min Zhao, Fengpeng Wu, Shaowu Jing, Jun Wang
Format: Article
Language:English
Published: Wiley 2021-11-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.14167
_version_ 1798033190339739648
author Yi Wang
Linlin Xiao
Jiandong Zhang
Xiaoyan Lv
Feng Cao
Min Zhao
Fengpeng Wu
Shaowu Jing
Jun Wang
author_facet Yi Wang
Linlin Xiao
Jiandong Zhang
Xiaoyan Lv
Feng Cao
Min Zhao
Fengpeng Wu
Shaowu Jing
Jun Wang
author_sort Yi Wang
collection DOAJ
description Abstract Background Brain metastases (BM) from esophageal carcinoma (EC) is clinically rare and has not yet been reported in elderly patients. This study aimed to investigate the clinicopathological characteristics, outcomes and prognostic factors of BM in elderly patients with EC, in order to provide guidance for clinical practice. Methods A total of 20 EC patients older than 65 years who were diagnosed with BM were identified from the fourth Hospital of Hebei Medical University between January 1, 2009 and December 31, 2018. Survival was evaluated by the Kaplan–Meier method and Cox proportional hazards models. Results The median time from diagnosis of EC to BM was 11.8 months (0–249.2 months). The median overall survival (OS) was 4.8 months (1.13–23.3 months), with 20% of patients achieving the 1‐year survival rate. Patients with KPS score of ≥70 had a significantly better OS than those with KPS score<70 (8.4 vs. 3.9 months, p = 0.033). Compared to patients without brain radiotherapy, patients with brain radiotherapy showed better outcomes in both median OS (8.4 vs. 2.9 months) and 1‐year survival rate (23.1% vs. 14.3%, p = 0.043). The median OS of patients with radiotherapy combined with chemotherapy and/or targeted therapy and radiotherapy alone was 9.7 months (3.4–23.3 months) and 7.2 months (1.7–18.4 months), respectively, with no significant difference between the two groups (p = 0.215). Conclusions Brain radiotherapy provided clinically meaningful survival benefit for elderly patients with BM from EC. Thus, active treatments for those patients might be required.
first_indexed 2024-04-11T20:26:20Z
format Article
id doaj.art-b2da3f3c8f8c4bbbb5dc85324e9c29fe
institution Directory Open Access Journal
issn 1759-7706
1759-7714
language English
last_indexed 2024-04-11T20:26:20Z
publishDate 2021-11-01
publisher Wiley
record_format Article
series Thoracic Cancer
spelling doaj.art-b2da3f3c8f8c4bbbb5dc85324e9c29fe2022-12-22T04:04:40ZengWileyThoracic Cancer1759-77061759-77142021-11-0112223005301010.1111/1759-7714.14167Clinicopathological characteristics and prognosis of brain metastases in elderly patients with esophageal carcinomaYi Wang0Linlin Xiao1Jiandong Zhang2Xiaoyan Lv3Feng Cao4Min Zhao5Fengpeng Wu6Shaowu Jing7Jun Wang8Department of Radiation Oncology Fourth Hospital of Hebei Medical University Shijiazhuang ChinaDepartment of Radiation Oncology Fourth Hospital of Hebei Medical University Shijiazhuang ChinaDepartment of Radiation Oncology The First Affiliated Hospital of Shandong First Medical University Jinan ChinaDepartment of Radiation Oncology Fourth Hospital of Hebei Medical University Shijiazhuang ChinaDepartment of Radiation Oncology Fourth Hospital of Hebei Medical University Shijiazhuang ChinaDepartment of Oncology, Hebei Chest Hospital Research Center of Hebei Lung Cancer Prevention and Treatment Shijiazhuang ChinaDepartment of Radiation Oncology Fourth Hospital of Hebei Medical University Shijiazhuang ChinaDepartment of Radiation Oncology Fourth Hospital of Hebei Medical University Shijiazhuang ChinaDepartment of Radiation Oncology Fourth Hospital of Hebei Medical University Shijiazhuang ChinaAbstract Background Brain metastases (BM) from esophageal carcinoma (EC) is clinically rare and has not yet been reported in elderly patients. This study aimed to investigate the clinicopathological characteristics, outcomes and prognostic factors of BM in elderly patients with EC, in order to provide guidance for clinical practice. Methods A total of 20 EC patients older than 65 years who were diagnosed with BM were identified from the fourth Hospital of Hebei Medical University between January 1, 2009 and December 31, 2018. Survival was evaluated by the Kaplan–Meier method and Cox proportional hazards models. Results The median time from diagnosis of EC to BM was 11.8 months (0–249.2 months). The median overall survival (OS) was 4.8 months (1.13–23.3 months), with 20% of patients achieving the 1‐year survival rate. Patients with KPS score of ≥70 had a significantly better OS than those with KPS score<70 (8.4 vs. 3.9 months, p = 0.033). Compared to patients without brain radiotherapy, patients with brain radiotherapy showed better outcomes in both median OS (8.4 vs. 2.9 months) and 1‐year survival rate (23.1% vs. 14.3%, p = 0.043). The median OS of patients with radiotherapy combined with chemotherapy and/or targeted therapy and radiotherapy alone was 9.7 months (3.4–23.3 months) and 7.2 months (1.7–18.4 months), respectively, with no significant difference between the two groups (p = 0.215). Conclusions Brain radiotherapy provided clinically meaningful survival benefit for elderly patients with BM from EC. Thus, active treatments for those patients might be required.https://doi.org/10.1111/1759-7714.14167brain metastaseselderly patientsesophageal carcinomaprognosisradiotherapy
spellingShingle Yi Wang
Linlin Xiao
Jiandong Zhang
Xiaoyan Lv
Feng Cao
Min Zhao
Fengpeng Wu
Shaowu Jing
Jun Wang
Clinicopathological characteristics and prognosis of brain metastases in elderly patients with esophageal carcinoma
Thoracic Cancer
brain metastases
elderly patients
esophageal carcinoma
prognosis
radiotherapy
title Clinicopathological characteristics and prognosis of brain metastases in elderly patients with esophageal carcinoma
title_full Clinicopathological characteristics and prognosis of brain metastases in elderly patients with esophageal carcinoma
title_fullStr Clinicopathological characteristics and prognosis of brain metastases in elderly patients with esophageal carcinoma
title_full_unstemmed Clinicopathological characteristics and prognosis of brain metastases in elderly patients with esophageal carcinoma
title_short Clinicopathological characteristics and prognosis of brain metastases in elderly patients with esophageal carcinoma
title_sort clinicopathological characteristics and prognosis of brain metastases in elderly patients with esophageal carcinoma
topic brain metastases
elderly patients
esophageal carcinoma
prognosis
radiotherapy
url https://doi.org/10.1111/1759-7714.14167
work_keys_str_mv AT yiwang clinicopathologicalcharacteristicsandprognosisofbrainmetastasesinelderlypatientswithesophagealcarcinoma
AT linlinxiao clinicopathologicalcharacteristicsandprognosisofbrainmetastasesinelderlypatientswithesophagealcarcinoma
AT jiandongzhang clinicopathologicalcharacteristicsandprognosisofbrainmetastasesinelderlypatientswithesophagealcarcinoma
AT xiaoyanlv clinicopathologicalcharacteristicsandprognosisofbrainmetastasesinelderlypatientswithesophagealcarcinoma
AT fengcao clinicopathologicalcharacteristicsandprognosisofbrainmetastasesinelderlypatientswithesophagealcarcinoma
AT minzhao clinicopathologicalcharacteristicsandprognosisofbrainmetastasesinelderlypatientswithesophagealcarcinoma
AT fengpengwu clinicopathologicalcharacteristicsandprognosisofbrainmetastasesinelderlypatientswithesophagealcarcinoma
AT shaowujing clinicopathologicalcharacteristicsandprognosisofbrainmetastasesinelderlypatientswithesophagealcarcinoma
AT junwang clinicopathologicalcharacteristicsandprognosisofbrainmetastasesinelderlypatientswithesophagealcarcinoma